Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Lamia H Ali, Aliaa M Higazi, Hend M Moness, Naglaa M Farag, Zienab M Saad, Hamdy A Moukareb, Wael Soliman, Ghada El Sagheer, Sahar R Abd El Hamid & Haytham Abdl Hamid. (2019) Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma. Clinical and Experimental Gastroenterology 12, pages 51-66.
Read now
Read now
Yasser M. Fouad, Hala I. Mohamed, Enas M. kamal & Mohamed A. Rasek. (2016) Clinical significance and diagnostic value of serum dickkopf-1 in patients with hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 51:9, pages 1133-1137.
Read now
Read now
Maria Pleguezuelo, Giacomo Germani, Laura Marelli, Elias Xiruochakis, Maria Misseri, Pinelopi Manousou, Vasiliki Arvaniti & Andrew K Burroughs. (2008) Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2:6, pages 761-784.
Read now
Read now
Nikki PY Lee, S T Cheung, Ronnie TP Poon, Sheung-Tat Fan & John M Luk. (2007) Genomic and Proteomic Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma. Biomarkers in Medicine 1:2, pages 273-284.
Read now
Read now
Jeng-Eing Jeng, Lea-Yea Chuang, Wang-Lung Chuang, Jan-Gowth Chang & Jung-Fa Tsai. (2007) Insulin-Like Growth Factor II in Hepatocellular Carcinoma. Biomarkers in Medicine 1:2, pages 261-271.
Read now
Read now
Articles from other publishers (30)
Tsunekazu Oikawa, Kohji Yamada, Akihito Tsubota, Chisato Saeki, Naoko Tago, Chika Nakagawa, Kaoru Ueda, Hiroshi Kamioka, Tomohiko Taniai, Koichiro Haruki, Masanori Nakano, Yuichi Torisu, Toru Ikegami, Kiyotsugu Yoshida & Masayuki Saruta. (2023) Protein Kinase C Delta Is a Novel Biomarker for Hepatocellular Carcinoma. Gastro Hep Advances 2:1, pages 83-95.
Crossref
Crossref
Deepak Kumar, Manasi Das, Alexis Oberg, Debashis Sahoo, Panyisha Wu, Consuelo Sauceda, Lily Jih, Lesley G. Ellies, Magda T. Langiewicz, Supriya Sen & Nicholas J. G. Webster. (2022) Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma. Advanced Science 9:21.
Crossref
Crossref
Hoang Van Tong, Pham Van Dung, Nguyen Thi Mong Diep & Nguyen Linh Toan. 2022. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach.
Ravikiran Tekupalli, Santosh Anand, Sowbhagya Ramachandregowda & Anupama Sindhghatta Kariyappa. 2022. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2
195
208
.
Hidenori Toyoda, Kan Kikuchi, Yuki Tsuruta, Atsushi Hiraoka, Kunihiko Tsuji & Junko Tanaka. (2021) Utility of serological tumor biomarkers for surveillance of hepatocellular carcinoma in patients undergoing dialysis. Nephrology Dialysis Transplantation 36:6, pages 1097-1103.
Crossref
Crossref
Ming Li, Pengcheng Sun, Kaikai Dong, Ye Xin, Aslee TaiLulu, Qinyu Li, Jing Sun, Min Peng & Ping Shi. (2021) Chemerin reverses the malignant phenotype and induces differentiation of human hepatoma SMMC7721 cells. Archives of Pharmacal Research 44:2, pages 194-204.
Crossref
Crossref
N Hasan, M Mukim, P Sharma, U. S. Baghel & M. Khalid. (2019) CURRENT UPDATES ON DIAGNOSTIC BIOMARKERS OF HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 56:06, pages 7-23.
Crossref
Crossref
Teh‐Ia Huo, Chia‐Yang Hsu & Po‐Hong Liu. (2018) Magic mirror on the wall: Which is the best biomarker for hepatocellular carcinoma?. Hepatology 67:6, pages 2482-2483.
Crossref
Crossref
Agnieszka Adamek & Aldona Kasprzak. (2018) Insulin-Like Growth Factor (IGF) System in Liver Diseases. International Journal of Molecular Sciences 19:5, pages 1308.
Crossref
Crossref
Nearmeen M. Rashad, Amal S. El-Shal, Eman H. Abd Elbary, Mohamed H. Abo Warda & Osama Hegazy. (2014) Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma. Cytokine 68:1, pages 50-58.
Crossref
Crossref
Jen-Eing Jeng, Meng-Feng Tsai, Hey-Ru Tsai, Lea-Yea Chuang, Zu-Yau Lin, Min-Yuh Hsieh, Shinn-Chern Chen, Wan-Lung Chuang, Liang-Yen Wang, Min-Lung Yu, Chia-Yen Dai & Jung-Fa Tsai. (2013) Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma. Tumor Biology 35:4, pages 3689-3698.
Crossref
Crossref
Jung-Fa Tsai, Jen-Eing Jeng & Wan-Long Chuang. (2012) Dickkopf-1 and hepatocellular carcinoma. The Lancet Oncology 13:10, pages e410.
Crossref
Crossref
C. Morace, M. Cucunato, R. Bellerone, G. De Caro, S. Crinò, A. Fortiguerra, F. Spadaro, A. Zirilli, A. Alibrandi, P. Consolo, C. Luigiano, M.L. Resta, O. Ferraù & A. Spadaro. (2012) Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?. European Journal of Internal Medicine 23:6, pages e157-e161.
Crossref
Crossref
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran & Vivek Kohli. (2012) Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 82:2, pages 116-140.
Crossref
Crossref
Tara Behne & M. Sitki Copur. (2012) Biomarkers for Hepatocellular Carcinoma. International Journal of Hepatology 2012, pages 1-7.
Crossref
Crossref
Agata Zirilli & Angela Alibrandi. 2012. Advanced Statistical Methods for the Analysis of Large Data-Sets. Advanced Statistical Methods for the Analysis of Large Data-Sets
69
78
.
Meng Fang, Yun‐Peng Zhao, Fei‐Guo Zhou, Lun‐Gen Lu, Peng Qi, Hao Wang, Kun Zhou, Shu‐Han Sun, Cui‐Ying Chen & Chun‐Fang Gao. (2010)
N
‐glycan based models improve diagnostic efficacies in hepatitis B virus‐related hepatocellular carcinoma
. International Journal of Cancer 127:1, pages 148-159.
Crossref
Crossref
Nilani Jeyaratnaganthan, Henning Grønbæk, Peter Holland‐Fischer, Ulrick Espelund, Jian‐Wen Chen, Allan Flyvbjerg, Hendrik Vilstrup & Jan Frystyk. (2010) Ascites from patients with alcoholic liver cirrhosis contains higher IGF‐I bioactivity than serum. Clinical Endocrinology 72:5, pages 625-632.
Crossref
Crossref
M. Birth, T. H. Ittel & P. L. PereiraF. G. Bader, G. Auer, U.J. Roblick, H.-P. Bruch & J.K. Habermann. 2010. Hepatobiliäre und Pankreastumoren. Hepatobiliäre und Pankreastumoren
88
105
.
Smruti Mohanty & Donald Jensen. 2009. Hepatocellular Carcinoma. Hepatocellular Carcinoma
62
81
.
Anuradha Budhu, Junfang Ji & Xin Wei Wang. 2010. Hepatocellular Carcinoma. Hepatocellular Carcinoma
131
182
.
Hidenori Toyoda, Takashi Kumada, Yukio Osaki, Hiroko Oka & Masatoshi Kudo. (2007) Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma. Hepatology Research 37:s2.
Crossref
Crossref
Biswajit Mukherjee, Tanushree Das, Shampa Ghosh & Subrata Datta. (2007) Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats. European Journal of Cancer Prevention 16:4, pages 363-371.
Crossref
Crossref
Teh‐Ia Huo, Cheng‐Yuan Hsia, Chi‐Jen Chu, Yi‐Hsiang Huang, Wing‐Yiu Lui, Jaw‐Ching Wu, Pui‐Ching Lee, Chin‐Wen Chi & Shou‐Dong Lee. (2007) The predictive ability of serum α‐fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. Journal of Surgical Oncology 95:8, pages 645-651.
Crossref
Crossref
C.-Y. Hsia, T.-I. Huo, S.-Y. Chiang, M.-F. Lu, C.-L. Sun, J.-C. Wu, P.-C. Lee, C.-W. Chi, W.-Y. Lui & S.-D. Lee. (2007) Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 33:2, pages 208-212.
Crossref
Crossref
Raphaël Saffroy, Patrick Pham, Maâmar Reffas, Mohamed Takka, Antoinette Lemoine & Brigitte Debuire. (2007) New perspectives and strategy research biomarkers for hepatocellular carcinoma. Clinical Chemical Laboratory Medicine 45:9.
Crossref
Crossref
Lorinda M. Wright, Jeff T. Kreikemeier & Claus J. Fimmel. (2007) A concise review of serum markers for hepatocellular cancer. Cancer Detection and Prevention 31:1, pages 35-44.
Crossref
Crossref
Patrick Pham, Raphaël Saffroy, Maámar Reffas, Mohamed Takka, Antoinette Lemoine & Brigitte Debuire. (2006) Dépistage, diagnostic et suivi biologique du carcinome hépatocellulaire. Revue Francophone des Laboratoires 2006:387, pages 73-77.
Crossref
Crossref
Mohamed Yousry Elsammak, Gamal M. Amin, Gehan M. Khalil, Wafaa S. Ragab & Mona M. Abaza. (2006) Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis. Clinical Biochemistry 39:6, pages 623-629.
Crossref
Crossref
Lin Zhou. (2006) Serum tumor markers for detection of hepatocellular carcinoma. World Journal of Gastroenterology 12:8, pages 1175.
Crossref
Crossref